An EpiPen epinephrine auto-injector is shown in Hendersonville, Texas on October 10, 2013. THE CANADIAN PRESS/AP, Mark Zaleski

Opposition parties blast minister for ‘dangerous’ EpiPen shortage

The NDP says the Liberals must take all steps necessary to prevent a future supply crunch.

The federal opposition parties called on the Trudeau government Wednesday to urgently address the shortage of life-saving epinephrine auto-injectors, known as EpiPens.

But the Conservatives and New Democrats differ as to how to ensure an adequate supply.

The NDP says the Liberals must take all steps necessary to prevent a future supply crunch, even if it means threatening the drug maker with the loss of its patent on the device.

The Conservatives, on the other hand, recommended the government encourage development of a Canadian-based supply chain.

Drug giant Pfizer said this week that the EpiPens it produces are in short supply, with the potential that adult doses may not be available at all in August, a peak month for people who rely on the injectors to treat serious allergic reactions.

“Many Canadians rely on EpiPens as life-saving devices,” said NDP health critic Don Davies.

“The minister of health should never have allowed this dangerous situation to develop, and now it’s on her to fix this immediately.”

The government said it was doing everything in its power to resolve the shortage as soon as possible, and advised Canadians with allergies to keep expired products.

“We continue to work closely with Pfizer Canada,” said Thierry Belair, a spokesman for Health Minister Ginette Petitpas Taylor.

Related: Canada could run out of EpiPens by end of August

Government officials noted that four other companies — Kaleo Pharma, Taro Pharmaceuticals, Valeant Canada and Lincoln Medical — have been approved to sell their epinephrine auto-injector products in Canada, but that Health Canada can’t compel a private company to market and supply product.

Critics warn the shortages could continue to happen because there is no firm requirement that manufacturers provide a consistent supply.

Hematologist and medical historian Jacalyn Duffin thinks the government should designate a list of “essential” medicines and also foster a homegrown manufacturing industry, particularly since most drugs sold in Canada are made elsewhere.

EpiPens are just one of dozens of medications in short supply, said Duffin, who tracks drug shortages on her website, CanadianDrugShortage.com.

U.S.-based Pfizer produces EpiPens at a facility near St. Louis, Missouri, and there are no alternatives sold in Canada.

Health Canada said anyone who has an anaphylactic reaction but has only an expired EpiPen should use the expired product and immediately call 911.

Davies called that response to the shortage “unacceptable.

“Health Canada must ensure that they are always available in sufficient supply. People’s health and their lives are on the line.”

The New Democrats called on the agency to make it a requirement for patent holders to supply the drug or lose their authorization to sell into the Canadian market.

“When foreign drug companies fail to supply Canadians with life-saving pharmaceuticals, the federal government can and must take action, including expropriating patents if necessary,” said Davies.

But such an approach would lead to an even more critical shortage, or no supply at all, said Conservative health critic Marilyn Gladu, who noted there have been significant supply crunches for EpiPens in Canada three times in the past 12 months.

“That would put us in an even worse position,” said Gladu.

Instead, the Trudeau government needs to set the conditions necessary to encourage Pfizer or other drug makers to set up production facilities in Canada, she said.

Pfizer also announced in April that it was running out of EpiPens, blaming the shortage on manufacturing delays. The shortage was felt at that time in the United Kingdom, but not the United States.

Gladu said pricing may be a factor driving Pfizer’s product distributors in determining where scarce supplies should be shipped.

EpiPens can cost around $300 in the U.S., although drug chains including CVS sell generic versions for less, while in Canada they are priced at around $100. They are sold for even less in the U.K.

Terry Pedwell, The Canadian Press

Like us on Facebook and follow us on Twitter.

Just Posted

Chilliwack art show fundraiser, One Foot by One Foot, helps mental health community

Sales from Chilliwack Visual Artists Association show benefit two local charities

Excel Martial Arts raises more than $5,000 for family of Chilliwack man killed in workplace accident

By-donation fundraiser event helps wife, three children of 28-year-old Nathan Appleton of Chilliwack

Seven Days in Chilliwack for the week of Dec. 17

A list of community events happening in Chilliwack from Dec. 17 to 23

Chilliwack Lions Club has a new place to call home

After more than five years without a headquarters, Chilliwack Lions Club moves into new hall

Sardis Falcons top Heritage Woods in field lacrosse opener

The Falcons rallied from a halftime hole to take a big win on the road in Port Moody.

REPLAY: B.C’s best video this week

In case you missed it, here’s a look at the replay-worth highlights from this week across the province

Canucks score 3 power-play goals in 4-2 win over Oilers

Vancouver sniper Boeser has 6 goals in last 5 games

Microscopic parasite found in Prince Rupert water affecting thousands

More than 12,000 residents affected by the boil water advisory issued Dec. 14

Trudeau lashes out at Conservatives over migration “misinformation”

Warning against the “dangers of populism,” Trudeau says using immigration as a wedge political issue puts Canada’s future at risk.

B.C. hockey coach creates ‘gear library’ to remove cost barrier of sport

Todd Hickling gathered donations and used gear to remove the cost barrier for kids to play hockey.

Canada’s ambassador meets with second detainee in China

Global Affairs says John McCallum, Canada’s ambassador to China, met with Spavor Sunday

‘They’re coming:’ Flying cars may appear in urban skies by 2023

Air taxis will number 15,000 and become a global market worth $32 billion by 2035

B.C. VIEWS: Andrew Wilkinson on taxes, ICBC and union changes

Opposition leader sees unpredictable year ahead in 2019

5 tips for self-care, mental wellness this holiday season

Ministry of Mental Health and Addictions urging British Columbians to prioritize self care through festive season

Most Read